BTIG Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $58
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsInitiationPrice Target
BTIG analyst Julian Harrison initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $58.
BTIG analyst Julian Harrison initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $58.